Evidence map›Paper›PMID 18513156›Full record

ArticleThe Journal of infectious diseases2008

Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006.

Laura K Certain, Marnie Briceño, Steven M Kiara, Alexis M Nzila, William M Watkins, Carol Hopkins Sibley

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present.International journal for parasitology. Drugs and drug resistance · 2012
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Laura K CertainDepartment of Genome Sciences, University of Washington, Seattle, Washington 98105-5065, USA.
Marnie Briceño
Steven M Kiara
Alexis M Nzila
William M Watkins
Carol Hopkins Sibley
Kenya Medical Research Institute · KEUniversity of Washington · USUniversity of Oxford · GB

Funding

Antifolates as Antimalarial DrugsR01AI055604 · NIAID · UNIVERSITY OF WASHINGTON · PI SIBLEY, CAROL HOPKINS · 2003 to 2007
$1.5M
NIAID NIH HHS AI 55604NIAID NIH HHS R01 AI055604Wellcome Trust 077092
6 · The paper itself

Abstract

Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plasmodium falciparum from Asia in the 1960s and subsequently spread to Africa. It is not known whether alleles that confer SP resistance also arose independently in Africa. We defined the coding region and microsatellite haplotypes of dhfr alleles in P. falciparum collected in Kilifi, Kenya, during 1987--2006, which spans the period when SP was first introduced. Isolates that carried a double-mutant or triple-mutant dhfr allele were detected at a low frequency, even during 1987--1988. Each of 2 double mutants carried a unique haplotype, and both were related to wild-type haplotypes from the same population. The number of isolates that carried a triple-mutant dhfr allele increased rapidly after introduction of SP and shared the haplotype of the triple mutant derived form Asia. We observed no triple-mutant alleles with haplotypes related to those of the Africa-derived wild-type and double-mutant alleles.

Indexed as

HaplotypesAnimalsAntimalarialsDrug ResistanceGene FrequencyHumansKenyaMalaria, FalciparumMicrosatellite RepeatsPlasmodium falciparumPyrimethamineTime FactorsAntimalarialsPyrimethamine

Identifiers

PMID18513156
PMCPMC2680814
OpenAlexW2126176745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.